Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,695,239
+$2,971,832 QoQ
Shares Held
444,674
+551.6% QoQ
Ownership
0.680%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 201 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ARVN ranks #165 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,695,239 | 444,674 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $723,407 | 68,246 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,979,634 | 166,917 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,409,158 | 400,136 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,519,364 | 1,021,653 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,336,669 | 475,309 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $39,077,257 | 2,038,459 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,614,965 | 471,578 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,824,275 | 256,359 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,138,135 | 294,044 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,577,543 | 256,986 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $6,279,653 | 319,738 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $9,369,946 | 377,516 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,915,951 | 399,559 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,208,529 | 327,639 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $13,218,245 | 297,106 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $13,228,759 | 314,297 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $27,796,717 | 413,027 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $23,532,041 | 286,487 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,768,011 | 143,198 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,076,456 | 65,928 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $123,144 | 1,863 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,306,986 | 15,389 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $57,254 | 2,425 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $792,583 | 23,631 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $556,744 | 13,815 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||